Xconomy: Indiana top stories News, Articles and Opinions

Results for “”

Entry	Author	Date	Location
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More	Alex Lash	09/20/19	National
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?	Alex Lash	09/19/19	National
After First Look at House Drug Plan, Stocks Rise Slightly	Alex Lash	09/10/19	National
Herceptin Inventors, Immunology Pioneers Take Home 2019 Lasker Awards	Ben Fidler	09/10/19	National
At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More	Ben Fidler	09/09/19	National
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone	Frank Vinluan	09/06/19	National
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss	Ben Fidler	09/03/19	Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More	Alex Lash	08/30/19	National
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)	Alex Lash	08/26/19	National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More	Frank Vinluan	08/23/19	National
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint	Frank Vinluan	08/20/19	Indiana
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More	Alex Lash	08/16/19	National
Four New Drugs Are Around the Corner. Here’s What You Need to Know.	Ben Fidler	08/15/19	National
Inari Reaps $89M and Eyes Global Farm Markets for Gene-Edited Seeds	Frank Vinluan	08/06/19	Boston
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More	Frank Vinluan	08/02/19	National
Elanco Boosts Vaccine Portfolio With $60M Prevtec Acquisition	Frank Vinluan	08/01/19	Indiana
White House Floats Canadian Import Plan But Excludes Many Costly Drugs	Frank Vinluan	07/31/19	National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston	Angela Shah	07/31/19	National
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data	Ben Fidler	07/26/19	Boston
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More	Ben Fidler	07/26/19	National
As Castle Bio Jumps on IPO Train, Industry Trends Suggest Slowdown	Frank Vinluan	07/25/19	National
Could Facebook’s Crypto Break Financial System? Congress Airs Fears	Bernadette Tansey	07/19/19	San Francisco
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More	Frank Vinluan	07/19/19	National
Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts	Frank Vinluan	07/18/19	National
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More	Alex Lash	07/12/19	National
Amgen, Novartis BACE Inhibitor Joins List of Failed Alzheimer’s Drugs	Frank Vinluan	07/11/19	National
Trump Kills His Administration’s Plan to End Secret Drug Rebates	Alex Lash	07/11/19	National
How Do YOU Think the Internet Will Evolve? A Sampling of Your Tweets	Wade Roush	07/09/19	National
Future of the Internet: What Scares Networking Pioneer Radia Perlman	Wade Roush	07/08/19	National
Why Ethernet Inventor Bob Metcalfe is an Internet Optimist	Wade Roush	07/08/19	National
Page 1 of 24	next page »